Intervertebral Disk Degeneration, Intervertebral Disk Displacement
Conditions
Keywords
Anterior cervical discectomy and fusion, NovoMax, Bioactive Glass-ceramic Intervertebral Spacer
Brief summary
The purpose of this study is to evaluate the efficacy and safety of NovoMax™ in Anterior Cervical Interbody Fusion - Comparison of NovoMax™ versus ChronOs®.
Interventions
The ACDF surgery will be carried out with Cervios ChronOs after randomization procedure.
The ACDF surgery will be carried out with NovoMax™ after randomization procedure.
Sponsors
Study design
Intervention model description
Treatment group: Bioactive Glass-Ceramic Spacer (NovoMax™) Active comparator: a PEEK cage Filled with β-Tricalcium Phosphate
Eligibility
Inclusion criteria
* The patient who is expected to receive anterior cervical discectomy and fusion operation. * Volunteer for this study with written consent.
Exclusion criteria
* Patient with cervical spine fracture, infection and malignant tumor * Below -3.5 T-score by DEXA bone densitometry * Patient who is not suitable for this study judged by principal investigator
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Bone Fusion With CT and Dynamic radiographs(X-ray)(Post operative 6 Months) | at 6 months after surgery (ACDF) | Evaluation of bone fusion between bone substitutes and cervical vertebral endplates with 3-dimensional CT and X-ray at 6 months after operation (ACDF). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| VAS of Neck Pain(Post operative 6 Months) | at 6 months after surgery (ACDF) | Evaluation of neck pain using the visual analogue scale (VAS) at 6 months after operation (ACDF). Reported pain using VAS was recorded and evaluated. Patients were instructed to make a mark on a horizontally-oriented, 10-point VAS labeled no pain (zero point) at the far left and greatest pain (ten point) at the far right. |
Countries
South Korea